Our work also highlighted that miR-223-3p from ADSC-EVs also reduced the ALT and AST levels, and hydroxyproline level in vivo, suggesting restoration of liver functions [40] and amelioration of NAFLD [41,42]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.